» Articles » PMID: 29704059

Contemporary Rates of Adherence to International Guidelines for Pelvic Lymph Node Dissection in Radical Cystectomy: a Population-based Study

Abstract

Objective: To examine the rates of adherence to guidelines for pelvic lymph node dissection (PLND) in patients treated with radical cystectomy (RC) and to identify predictors of omitting PLND.

Materials And Methods: We relied on 66,208 patients treated with RC between 2004 and 2013 within the National Inpatients Sample (NIS) database. We examined the rates of PLND according to year of surgery, patient and hospital characteristics. Univariate and multivariate logistic regression analyses assessed the probability of PLND use, after adjusting for year of surgery, age, gender, race, comorbidities, hospital location, teaching status and hospital surgical volume.

Results: Overall, PLND was performed on 54,223 (81.9%) RC patients. The rates PLND at RC significantly increased over the study period from 72.3% in 2004 to 85.9% in 2013, (p < 0.001). Barriers to PLND at RC consisted of female gender (OR: 1.31; 95% CI 1.25-1.38; p < 0.001), African American race (OR: 1.21; 95% CI 1.10-1.32; p < 0.001), intermediate (OR: 1.78; 95% CI 1.68-1.88; p < 0.001) or low surgical volume institutions (OR: 2.59; 95% CI 2.44-2.74; p < 0.001), non-teaching institution status (OR: 1.21; 95% CI 1.15-1.27; p < 0.001) and rural hospital location (OR: 1.13; 95% CI 1.01-1.25; p = 0.03).

Conclusions: It is encouraging to note increasing rates of PLND at RC over time. Both patients and hospital characteristics influence PLND rates. More efforts should be aimed at reducing inequalities in PLND at RC due to these highly modifiable variables.

Citing Articles

Quality indicators for the management of muscle-invasive bladder cancer in the perioperative setting of radical cystectomy: a narrative review.

Konig F, Pradere B, Grossmann N, Quhal F, Rajwa P, Laukhtina E Transl Cancer Res. 2022; 11(4):908-917.

PMID: 35571640 PMC: 9091037. DOI: 10.21037/tcr-21-1116.


Modeling 1-year Relapse-free Survival After Neoadjuvant Chemotherapy and Radical Cystectomy in Patients with Clinical T2-4N0M0 Urothelial Bladder Carcinoma: Endpoints for Phase 2 Trials.

Bandini M, Briganti A, Plimack E, Niegisch G, Yu E, Bamias A Eur Urol Oncol. 2019; 2(3):248-256.

PMID: 31200838 PMC: 7552889. DOI: 10.1016/j.euo.2018.08.009.

References
1.
Dobruch J, Daneshmand S, Fisch M, Lotan Y, Noon A, Resnick M . Gender and Bladder Cancer: A Collaborative Review of Etiology, Biology, and Outcomes. Eur Urol. 2015; 69(2):300-10. DOI: 10.1016/j.eururo.2015.08.037. View

2.
Konety B, Dhawan V, Allareddy V, Joslyn S . Impact of hospital and surgeon volume on in-hospital mortality from radical cystectomy: data from the health care utilization project. J Urol. 2005; 173(5):1695-700. DOI: 10.1097/01.ju.0000154638.61621.03. View

3.
Witjes J, Comperat E, Cowan N, De Santis M, Gakis G, Lebret T . EAU guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2013 guidelines. Eur Urol. 2013; 65(4):778-92. DOI: 10.1016/j.eururo.2013.11.046. View

4.
Vieweg J, Gschwend J, Herr H, Fair W . Pelvic lymph node dissection can be curative in patients with node positive bladder cancer. J Urol. 1999; 161(2):449-54. View

5.
Spiess P, Agarwal N, Bangs R, Boorjian S, Buyyounouski M, Clark P . Bladder Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2017; 15(10):1240-1267. DOI: 10.6004/jnccn.2017.0156. View